All ETFs

JFNCX

ETF

JFNCX · UNKNOWN · 87 holdings

€ 66,29

▲ € 1,26 (1,94%)

Day Range

—

52-Week Range

—

Volume

—

Openen —

50D / 200D Gem.

—

50D / 200D Gem.

—

About JFNCX

No description available for this ETF.

Fund Details

Expense Ratio: —
Inception Date: —
Prev. Close: € 65,03
Exchange: UNKNOWN
Currency: USD
Holdings As Of: Apr 10, 2026
Tracked Holdings: 88.5%
HHI Score: 254,35
Top Sector: Healthcare (90.52231%)

Performance

Low (19,2%) ↗ Recovering

▲ 1,96%

▼ -0,17%

▼ -1,16%

▲ 13,54%

YTD

▼ -1,13%

▲ 26,50%

▲ 15,33%

Positive 1W (+1.96%) after negative 1M (-0.17%) — trend may be reversing

Price History

Concentration Risk

39,31% Balanced

Diversified Concentrated

The top 10 holdings represent 39,31% of the fund. A moderate concentration level — the fund balances top holdings with broader diversification.

Top Holdings Today

Weighted by position size

LLY

▼ -1,65%

JNJ

▼ -1,18%

AZN

▼ -0,47%

UNH

▼ -0,84%

ABBV

▼ -2,10%

ABT

▼ -2,36%

ARGX

▼ -0,11%

BSX

▲ 0,83%

SNYNF

▼ -1,49%

NVS

▼ -0,65%

Weighted avg. of top holdings ▼ -1,11%

Sector Allocation

Healthcare

90,52%

Manufacturing

3,02%

Top 10 Holdings

39,31% of fund

LLY Eli Lilly & Co.

8,31%

JNJ Johnson & Johnson

5,01%

AZN AstraZeneca PLC

4,22%

UNH UnitedHealth Group Inc.

4,21%

ABBV AbbVie Inc.

3,58%

ABT Abbott Laboratories

3,16%

ARGX Argenx SE

2,82%

BSX Boston Scientific Corporation

2,74%

SNYNF Sanofi SA

2,69%

NVS Novartis AG

2,56%

Other positions

2,48%

All Holdings (87)

Top 10: 39,31% of fund

#	Ticker	Name	Weight	Shares	Market Value
1	LLY	Eli Lilly & Co.	8,31%	497.962	379,95 M
2	JNJ	Johnson & Johnson	5,01%	1,24 M	229,16 M
3	AZN	AstraZeneca PLC	4,22%	1,26 M	193,09 M
4	UNH	UnitedHealth Group Inc.	4,21%	556.891	192,29 M
5	ABBV	AbbVie Inc.	3,58%	706.535	163,59 M
6	ABT	Abbott Laboratories	3,16%	1,08 M	144,64 M
7	ARGX	Argenx SE	2,82%	175.105	129,15 M
8	BSX	Boston Scientific Corporation	2,74%	1,29 M	125,49 M
9	SNYNF	Sanofi SA	2,69%	1,30 M	122,94 M
10	NVS	Novartis AG	2,56%	914.366	117,26 M
11	TMO	Thermo Fisher Scientific Inc	2,30%	216.413	104,96 M
12	AMGN	Amgen Inc.	2,24%	362.293	102,24 M
13	ISRG	Intuitive Surgical Inc.	2,14%	219.297	98,08 M
14	HCA	HCA Healthcare Inc	2,13%	228.288	97,30 M
15	VRTX	Vertex Pharmaceuticals Incorporated	2,09%	243.863	95,51 M
16	DHR	Danaher Corporation	1,84%	424.559	84,17 M
17	SYK	Stryker Corporation	1,83%	225.946	83,53 M
18	BBIO	Bridgebio Pharma Inc	1,71%	1,50 M	78,06 M
19	ASND	Ascendis Pharma A/S	1,66%	382.422	76,03 M
20	MDT	Medtronic PLC	1,66%	795.435	75,76 M
21	CVS	CVS Health Corp	1,65%	998.078	75,25 M
22	RNA	Avidity Biosciences Inc.	1,58%	1,66 M	72,18 M
23	MDGL	Madrigal Pharmaceuticals Inc	1,50%	149.654	68,64 M
24	SLNO	Soleno Therapeutics Inc	1,50%	1,02 M	68,64 M
25	MCK	Mckesson Corp.	1,44%	85.319	65,91 M
26	RVMD	Revolution Medicines Inc	1,35%	1,32 M	61,70 M
27	AKRO	Akero Therapeutics Inc	1,34%	1,29 M	61,22 M
28	GILD	Gilead Sciences Inc.	1,15%	475.138	52,74 M
29	COR	Cencora Inc	1,12%	164.570	51,43 M
30	MIRM	Mirum Pharmaceuticals Inc.	1,05%	654.790	48,00 M
31	DXCM	DexCom Inc	0,96%	654.827	44,06 M
32	PTCT	PTC Therapeutics, Inc.	0,96%	712.301	43,71 M
33	GMED	Globus Med Inc	0,94%	748.396	42,86 M
34	TEVA	Teva Pharmaceutical Industries Ltd.	0,92%	2,08 M	41,99 M
35	TVTX	Travere Therapeutics Inc	0,84%	1,62 M	38,64 M
36	DSKYF	Daiichi Sankyo Co Ltd.	0,84%	1,71 M	38,25 M
37	DYN	Dyne Therapeutics Inc.	0,79%	2,86 M	36,16 M
38	EW	Edwards Lifesciences Corporation	0,79%	463.525	36,05 M
39	PCVX	Vaxcyte Inc	0,79%	998.056	35,95 M
40	COO	The Cooper Companies, Inc.	0,71%	475.586	32,61 M
41	ELV	Elevance Health Inc.	0,70%	99.500	32,15 M
42	BDX	Becton, Dickinson and Company	0,69%	167.825	31,41 M
43	MTSR	Metsera Inc.	0,67%	585.969	30,66 M
44	JANUS CAPITAL GROUP	JANUS CAPITAL GROUP INC	0,66%	30,06 M	30,06 M
45	LNTH	Lantheus Holdings Inc	0,61%	544.082	27,91 M
46	NUVL	Nuvalent Inc	0,57%	302.812	26,19 M
47	PEN	Penumbra Inc.	0,52%	93.774	23,75 M
48	AVDL	Avadel Pharmaceuticals PLC	0,50%	1,50 M	22,96 M
49	0348323Z	HeartFlow Inc	0,49%	662.334	22,29 M
50	ALNY	Alnylam Pharmaceuticals Inc.	0,49%	48.877	22,29 M
51	RYTM	Rhythm Pharmaceuticals Inc	0,49%	220.147	22,23 M
52	UTHR	United Therapeutics Corporation	0,46%	50.486	21,16 M
53	ZTS	Zoetis Inc.	0,46%	144.275	21,11 M
54	IDYA	IDEAYA Biosciences Inc.	0,46%	767.758	20,89 M
55	INSM	Insmed Inc	0,46%	144.837	20,86 M
56	STE	Steris PLC	0,45%	82.962	20,53 M
57	PRAX	Praxis Precision Medicines Inc	0,44%	382.496	20,27 M
58	ACLX	Arcellx Inc	0,44%	244.065	20,04 M
59	ZLAB	Zai Lab Ltd.	0,43%	579.330	19,63 M
60	TARS	Tarsus Pharmaceuticals Inc	0,39%	298.519	17,74 M
61	NBIX	Neurocrine Biosciences Inc	0,38%	124.275	17,45 M
62	ARDX	Ardelyx Inc	0,38%	3,15 M	17,34 M
63	SHC	Sotera Health Company	0,37%	1,07 M	16,85 M
64	HUM	Humana Inc.	0,37%	64.704	16,83 M
65	LEGN	Legend Biotech Corporation	0,31%	437.283	14,26 M
66	GPCR	Structure Therapeutics Inc	0,30%	491.016	13,75 M
67	BHVN	Biohaven Ltd	0,29%	898.042	13,48 M
68	SRRK	Scholar Rock Holding Corp.	0,29%	360.796	13,44 M
69	XENE	Xenon Pharmaceuticals Inc	0,28%	317.935	12,77 M
70	CRNX	Crinetics Pharmaceuticals Inc.	0,28%	304.704	12,69 M
71	TFX	Teleflex Incorporated	0,27%	102.708	12,57 M
72	CNC	Centene Corp.	0,27%	345.196	12,32 M
73	JANX	Janux Therapeutics Inc	0,26%	482.882	11,80 M
74	EWTX	Edgewise Therapeutics Inc.	0,26%	724.994	11,76 M
75	ALGN	Align Technology Inc.	0,25%	92.443	11,58 M
76	Janus Henderson Cash	Janus Henderson Cash Collateral Fund	0,25%	11,31 M	11,31 M
77	INSP	Inspire Medical Systems Inc	0,24%	148.268	11,00 M
78	ILMN	Illumina Inc	0,21%	103.520	9,83 M
79	APGE	Apogee Therapeutics Inc.	0,18%	205.848	8,18 M
80	FOLD	Amicus Therapeutics Inc.	0,17%	1,01 M	7,96 M
81	FDMT	4D Molecular Therapeutics Inc	0,16%	851.188	7,40 M
82	LXEO	Lexeo Therapeutics Inc	0,09%	642.299	4,26 M
83	IMNM	Immunome Inc	0,09%	349.668	4,09 M
84	ETNB	89bio Inc.	0,06%	199.694	2,94 M
85	KARDIUM SERIES 8 CLA	KARDIUM SERIES 8 CLASS D PREFERRED SHARES USD	0,01%	145.275	4,89 M
86	1426815D	Magnolia Medical Technologies	0,00%	37.748	37,75
87	Magnolia Medical Tec	Magnolia Medical Technologies	0,00%	1	0,0

Showing top 10 of 87 holdings · Listed: 97,52% · 2,48% in other positions

Related ETFs